<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT943-14210</title>
	</head>
	<body>
		<main>
			<p>940715 FT  15 JUL 94 / UK Company News: Cortecs signs Japanese agreement Cortecs, the biotechnology company which recently gained a London listing, has signed an exclusive agreement for distribution in Japan of its detection kits for Helicobacter Pylori, the bacterium involved in the development of peptic ulcers. Zenyaku Kogyo, a Japanese pharmaceuticals company with sales of Dollars 160m (Pounds 105.2m) last year, will undertake the registration for the kits and has agreed 'significant' milestone payments to Cortecs. The agreement contemplates sales of Pounds 20m over the first seven years in Japan.</p>
		</main>
</body></html>
            